Axiom Investment Management LLC Astrazeneca PLC Transaction History

Axiom Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $15,906 - $40,725	300 New	300 $15,000
Q3 2019 Mar 16, 2021	SELL	$40.12 - $45.47 $290,749 - $329,521	-7,247 Closed	0 $0
Q2 2019 Mar 16, 2021	BUY	$37.28 - $41.68 $3,616 - $4,042	97 Added 1.36%	7,247 $298,000
Q1 2019 Mar 16, 2021	SELL	$35.49 - $43.02 $67,927 - $82,340	-1,914 Reduced 21.12%	7,150 $287,000
Q4 2018 Oct 23, 2020	BUY	$36.86 - $41.49 $334,099 - $376,065	9,064 New	9,064 $344,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Axiom Investment Management LLC with notifications on news.